Klp Kapitalforvaltning As Apellis Pharmaceuticals, Inc. Transaction History
Klp Kapitalforvaltning As
- $24.5 Billion
- Q3 2025
A detailed history of Klp Kapitalforvaltning As transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 15,600 shares of APLS stock, worth $317,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,600
Previous 15,600
-0.0%
Holding current value
$317,148
Previous $270,000
30.74%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding APLS
# of Institutions
329Shares Held
124MCall Options Held
4.12MPut Options Held
756K-
Avoro Capital Advisors LLC New York, NY12.2MShares$248 Million3.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.99MShares$203 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.64MShares$196 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.29MShares$189 Million0.04% of portfolio
-
Deep Track Capital, LP Greenwich, CT8MShares$163 Million5.71% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.23B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...